MedinCell Revenue vs. Current Ratio
| MDCLF Stock | USD 6.98 0.00 0.00% |
For MedinCell profitability analysis, we use financial ratios and fundamental drivers that measure the ability of MedinCell to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well MedinCell SA utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between MedinCell's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of MedinCell SA over time as well as its relative position and ranking within its peers.
MedinCell |
MedinCell SA Current Ratio vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining MedinCell's current stock value. Our valuation model uses many indicators to compare MedinCell value to that of its competitors to determine the firm's financial worth. MedinCell SA is rated top company in revenue category among its peers. It also is considered to be number one stock in current ratio category among its peers . The ratio of Revenue to Current Ratio for MedinCell SA is about 1,440,141 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the MedinCell's earnings, one of the primary drivers of an investment's value.MedinCell Revenue vs. Competition
MedinCell SA is rated top company in revenue category among its peers. Market size based on revenue of Biotechnology industry is now estimated at about 942.28 Million. MedinCell adds roughly 4.09 Million in revenue claiming only tiny portion of stocks in Biotechnology industry.
MedinCell Current Ratio vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
MedinCell |
| = | 4.09 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
MedinCell |
| = | 2.84 X |
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
MedinCell Current Ratio Comparison
MedinCell is currently under evaluation in current ratio category among its peers.
MedinCell Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in MedinCell, profitability is also one of the essential criteria for including it into their portfolios because, without profit, MedinCell will eventually generate negative long term returns. The profitability progress is the general direction of MedinCell's change in net profit over the period of time. It can combine multiple indicators of MedinCell, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
It develops solutions based on BEPO, a technology for long-acting injectable products based on proprietary copolymers and a biocompatible solvent, which solubilizes or suspends the active pharmaceutical ingredients. Its product candidates in formulation research comprise subcutaneous injections, such as mdc-WWM for contraception mdc-ANG for CNS related treatments mdc-ELK for depression and mdc-GRT for use in organ transplant, as well as perineural injections, including mdc-CMV for anesthesia and pain, and mdc-NVA for pain. Medincell is traded on OTC Exchange in the United States.
MedinCell Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on MedinCell. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of MedinCell position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the MedinCell's important profitability drivers and their relationship over time.
Use MedinCell in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if MedinCell position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MedinCell will appreciate offsetting losses from the drop in the long position's value.MedinCell Pair Trading
MedinCell SA Pair Trading Analysis
The ability to find closely correlated positions to MedinCell could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace MedinCell when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back MedinCell - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling MedinCell SA to buy it.
The correlation of MedinCell is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as MedinCell moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if MedinCell SA moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for MedinCell can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your MedinCell position
In addition to having MedinCell in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Computers Thematic Idea Now
Computers
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Computers theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Computers Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in MedinCell Pink Sheet
To fully project MedinCell's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of MedinCell SA at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include MedinCell's income statement, its balance sheet, and the statement of cash flows.